ADAMAS PHARMACEUTICALS (ADMS) Covered Calls

ADAMAS PHARMACEUTICALS covered calls Adamas Pharmaceuticals Inc is a specialty pharmaceutical company, is focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. Its portfolio includes Namzaric and Namenda XR.

You can sell covered calls on ADAMAS PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ADMS (prices last updated Tue 4:16 PM ET):

ADAMAS PHARMACEUTICALS (ADMS) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
27.24 -0.14 23.01 29.49 213K - 0.7B
Covered Calls For ADAMAS PHARMACEUTICALS (ADMS)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jul 20 25 1.95 27.54 -9.2% -839.5%
Aug 17 25 3.10 26.39 -5.3% -60.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Adamas Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that focuses on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. It achieves this by enhancing the pharmacokinetic profiles of proven drugs to create novel therapeutics for use alone and in fixed-dose combination products. The company's products are designed to provide improved tolerability, efficacy and dosing for the treatment of CNS disorders including Alzheimer's disease, Parkinson's disease and Traumatic Brain Injury. Adamas Pharmaceuticals was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA.